Alexandria New Medical Center (EGX:AMES)
Egypt · Delayed Price · Currency is EGP 147.22
-0.18 (-0.12%)
At close: Aug 25, 2026
EGX:AMES Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 492.8 | 467.9 | 353.16 | 277.73 | 261.03 | 275.16 | |
Revenue Growth | 17.86% | 32.49% | 27.16% | 6.40% | -5.13% | 22.08% |
Cost of Revenue | 341.66 | 321.28 | 251.61 | 214.54 | 186.87 | 174.17 |
Gross Profit | 151.15 | 146.62 | 101.54 | 63.19 | 74.16 | 100.99 |
Selling, General & Admin | 84.82 | 77.91 | 61.29 | 48.07 | 50.68 | 32.36 |
Other Operating Expenses | -3.61 | -3.45 | -2.37 | 4.9 | 4.74 | 14.55 |
Operating Expenses | 85.21 | 78.52 | 68.81 | 53.65 | 63.6 | 53.81 |
Operating Income | 65.93 | 68.1 | 32.73 | 9.54 | 10.57 | 47.17 |
Interest Expense | -0.67 | -0.39 | - | -1.86 | -0.42 | -2.52 |
Interest & Investment Income | 5.68 | 5.42 | 8 | 4.81 | 3.98 | 3.58 |
Currency Exchange Gain (Loss) | -0.04 | -0.19 | 1.16 | 1.52 | 0.54 | 0 |
EBT Excluding Unusual Items | 70.9 | 72.95 | 41.89 | 14.01 | 14.66 | 48.23 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -2.83 |
Gain (Loss) on Sale of Assets | 0.77 | 0.48 | 0.12 | 0.04 | 0.08 | 0.01 |
Pretax Income | 71.67 | 73.42 | 42.01 | 14.04 | 14.74 | 45.41 |
Income Tax Expense | 18.06 | 18.38 | 12.2 | 8.11 | 15.44 | 16.86 |
Net Income | 53.61 | 55.04 | 29.82 | 5.93 | -0.7 | 28.55 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 1.97 |
Net Income to Common | 53.61 | 55.04 | 29.82 | 5.93 | -0.7 | 26.58 |
Net Income Growth | 19.09% | 84.61% | 402.63% | - | - | 27.47% |
Shares Outstanding (Basic) | 125 | 125 | 125 | 125 | 125 | 125 |
Shares Outstanding (Diluted) | 125 | 125 | 125 | 125 | 125 | 125 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.43 | 0.44 | 0.24 | 0.05 | -0.01 | 0.21 |
EPS (Diluted) | 0.43 | 0.44 | 0.24 | 0.05 | -0.01 | 0.21 |
EPS Growth | 19.09% | 84.61% | 402.63% | - | - | 27.47% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.14 | 0.58 | -14.13 | -14.97 | -7.4 | 40.68 |
Free Cash Flow Per Share | 0.00 | 0.01 | -0.11 | -0.12 | -0.06 | 0.33 |
Dividend Per Share | - | - | - | - | - | 0.100 |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 30.67% | 31.34% | 28.75% | 22.75% | 28.41% | 36.70% |
Operating Margin | 13.38% | 14.56% | 9.27% | 3.44% | 4.05% | 17.14% |
Profit Margin | 10.88% | 11.76% | 8.44% | 2.14% | -0.27% | 9.66% |
Free Cash Flow Margin | 0.03% | 0.12% | -4.00% | -5.39% | -2.84% | 14.78% |
EBITDA | 84.42 | 82.3 | 43.75 | 19.68 | 20.8 | 72.28 |
EBITDA Margin | 17.13% | 17.59% | 12.39% | 7.08% | 7.97% | 26.27% |
D&A For EBITDA | 18.48 | 14.2 | 11.02 | 10.13 | 10.23 | 25.11 |
EBIT | 65.93 | 68.1 | 32.73 | 9.54 | 10.57 | 47.17 |
EBIT Margin | 13.38% | 14.56% | 9.27% | 3.44% | 4.05% | 17.14% |
Effective Tax Rate | 25.19% | 25.03% | 29.03% | 57.76% | 104.72% | 37.13% |